ASK1 SOLID FORMS OF AN ASK1 INHIBITOR

5-(4-시클로프로필-1H-이미다졸-1-일)-N-(6-(4-이소프로필-4H-1,2,4-트리아졸-3-일)피리딘-2-일)-2-플루오로-4-메틸벤즈아미드 (화합물 I)의 결정질 형태를 제조하고, 고체 상태로 특징화하였다. 상기 결정질 형태의 제조 방법 및 사용 방법이 또한 제공된다. Crystalline forms of 5-(4-cyclopropyl-1H-imidazol-1-yl)-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-2-fluoro-4-methylbenzamide (Compou...

Full description

Saved in:
Bibliographic Details
Main Authors LATHROP STEPHEN P, ANDRES MARK, CARRA ERNEST A, LAPINA OLGA VIKTOROVNA, YU LOK HIM, CHAN BRENDA J. BURKE, CHIU ANNA, SMOLENSKAYA VALERIYA, NOTTE GREGORY
Format Patent
LanguageEnglish
Korean
Published 23.08.2017
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract 5-(4-시클로프로필-1H-이미다졸-1-일)-N-(6-(4-이소프로필-4H-1,2,4-트리아졸-3-일)피리딘-2-일)-2-플루오로-4-메틸벤즈아미드 (화합물 I)의 결정질 형태를 제조하고, 고체 상태로 특징화하였다. 상기 결정질 형태의 제조 방법 및 사용 방법이 또한 제공된다. Crystalline forms of 5-(4-cyclopropyl-1H-imidazol-1-yl)-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-2-fluoro-4-methylbenzamide (Compound I) were prepared and characterized in the solid state:Also provided are processes of manufacture and methods of using the crystalline forms.
AbstractList 5-(4-시클로프로필-1H-이미다졸-1-일)-N-(6-(4-이소프로필-4H-1,2,4-트리아졸-3-일)피리딘-2-일)-2-플루오로-4-메틸벤즈아미드 (화합물 I)의 결정질 형태를 제조하고, 고체 상태로 특징화하였다. 상기 결정질 형태의 제조 방법 및 사용 방법이 또한 제공된다. Crystalline forms of 5-(4-cyclopropyl-1H-imidazol-1-yl)-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-2-fluoro-4-methylbenzamide (Compound I) were prepared and characterized in the solid state:Also provided are processes of manufacture and methods of using the crystalline forms.
Author CHAN BRENDA J. BURKE
LAPINA OLGA VIKTOROVNA
ANDRES MARK
NOTTE GREGORY
CARRA ERNEST A
SMOLENSKAYA VALERIYA
CHIU ANNA
LATHROP STEPHEN P
YU LOK HIM
Author_xml – fullname: LATHROP STEPHEN P
– fullname: ANDRES MARK
– fullname: CARRA ERNEST A
– fullname: LAPINA OLGA VIKTOROVNA
– fullname: YU LOK HIM
– fullname: CHAN BRENDA J. BURKE
– fullname: CHIU ANNA
– fullname: SMOLENSKAYA VALERIYA
– fullname: NOTTE GREGORY
BookMark eNrjYmDJy89L5WRQdQz2NlQI9vfxdFFw8w_yDVbwd1Nw9FMAC3v6eXg6eYb4B_EwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUknjvICMDQ3MDA0szA2MzR2PiVAEA18wlWA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate ASK1 억제제의 고체 형태
ExternalDocumentID KR20170096036A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20170096036A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:58:15 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20170096036A3
Notes Application Number: KR20177020152
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170823&DB=EPODOC&CC=KR&NR=20170096036A
ParticipantIDs epo_espacenet_KR20170096036A
PublicationCentury 2000
PublicationDate 20170823
PublicationDateYYYYMMDD 2017-08-23
PublicationDate_xml – month: 08
  year: 2017
  text: 20170823
  day: 23
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies GILEAD SCIENCES, INC
RelatedCompanies_xml – name: GILEAD SCIENCES, INC
Score 3.0830889
Snippet 5-(4-시클로프로필-1H-이미다졸-1-일)-N-(6-(4-이소프로필-4H-1,2,4-트리아졸-3-일)피리딘-2-일)-2-플루오로-4-메틸벤즈아미드 (화합물 I)의 결정질 형태를 제조하고, 고체 상태로 특징화하였다. 상기 결정질 형태의 제조 방법 및 사용 방법이 또한 제공된다....
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title ASK1 SOLID FORMS OF AN ASK1 INHIBITOR
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170823&DB=EPODOC&locale=&CC=KR&NR=20170096036A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMbVMSgHVI7qWRqZJuiZJaYm6lhZmlrrmwMoh1SwxMdkQfJC2r5-ZR6iJV4RpBBNDDmwvDPic0HLw4YjAHJUMzO8l4PK6ADGI5QJeW1msn5QJFMq3dwuxdVGD9o4NzUETR2ouTrauAf4u_s5qzs623kFqfkEQOVBz3djMkZmBFdSQBp207xrmBNqXUoBcqbgJMrAFAM3LKxFiYMrOF2bgdIbdvSbMwOELnfIGMqG5r1iEQdUx2NtQIdjfx9NFAdh58w1W8HdTcPRTAAt7-nl4OnmG-AeJMii7uYY4e-gC7YuHey_eOwjZccZiDCzAjn-qBINCMrC1kWqSZJhqaJ5mkphmapmYYpFmamZsZpacbJCYlijJIIPPJCn80tIMXCAuaHzUyFiGgaWkqDRVFljBliTJgcMFAG06eZA
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ7Uaqw3rZqqVUlUbkQpsJQDMTxKQF4NoOmNLBQSo7GNxfj33V2p9tTbZiaZfSSz89r5FuBW0Yo5tSOCNlIKQS5qLGhjpAkqMQ4VwrgUGZB2GCH3WX6aKbMOvK97YRhO6DcDRyQaVRJ9b9h9vfxPYtnsbeXqvnglpMWjk-k230bHokoLR7xt6pNpbMcWb1m6n_BR8suj7rqEjB3YVSk-L3WeXkzal7LcNCrOIexNibyP5gg6b4s-9Kz132t92A_bkjcZttq3OoY7I_VFLo0Dz-ZI8BamXOxwRsQxshe5nullcXICN84ks1yBzJf_bS_3k83FSafQJYF_NQCuJN5GJRdiJaq1jGtFw_NxrSAJobJ8wDU-g-E2Sefb2dfQc7MwyAMv8i_ggLJornQkDaHbfH5Vl8TYNsUVO6MfRF18fQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ASK1+SOLID+FORMS+OF+AN+ASK1+INHIBITOR&rft.inventor=LATHROP+STEPHEN+P&rft.inventor=ANDRES+MARK&rft.inventor=CARRA+ERNEST+A&rft.inventor=LAPINA+OLGA+VIKTOROVNA&rft.inventor=YU+LOK+HIM&rft.inventor=CHAN+BRENDA+J.+BURKE&rft.inventor=CHIU+ANNA&rft.inventor=SMOLENSKAYA+VALERIYA&rft.inventor=NOTTE+GREGORY&rft.date=2017-08-23&rft.externalDBID=A&rft.externalDocID=KR20170096036A